These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 28492923)

  • 1. Sex- and Age-Adjusted Population Analysis of Prevalence Estimates for Hidradenitis Suppurativa in the United States.
    Garg A; Kirby JS; Lavian J; Lin G; Strunk A
    JAMA Dermatol; 2017 Aug; 153(8):760-764. PubMed ID: 28492923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of hidradenitis suppurativa in the United States: A sex- and age-adjusted population analysis.
    Garg A; Lavian J; Lin G; Strunk A; Alloo A
    J Am Acad Dermatol; 2017 Jul; 77(1):118-122. PubMed ID: 28285782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence Estimates for Hidradenitis Suppurativa among Children and Adolescents in the United States: A Gender- and Age-Adjusted Population Analysis.
    Garg A; Wertenteil S; Baltz R; Strunk A; Finelt N
    J Invest Dermatol; 2018 Oct; 138(10):2152-2156. PubMed ID: 29660301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overall and Subgroup Prevalence of Crohn Disease Among Patients With Hidradenitis Suppurativa: A Population-Based Analysis in the United States.
    Garg A; Hundal J; Strunk A
    JAMA Dermatol; 2018 Jul; 154(7):814-818. PubMed ID: 29800049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of hidradenitis suppurativa among tobacco smokers: a population-based retrospective analysis in the U.S.A.
    Garg A; Papagermanos V; Midura M; Strunk A
    Br J Dermatol; 2018 Mar; 178(3):709-714. PubMed ID: 28960235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining the race-specific prevalence of hidradenitis suppurativa at a large academic center; results from a retrospective chart review.
    Vaidya T; Vangipuram R; Alikhan A
    Dermatol Online J; 2017 Jun; 23(6):. PubMed ID: 28633744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States.
    Garg A; Birabaharan M; Strunk A
    J Am Acad Dermatol; 2018 Jul; 79(1):71-76. PubMed ID: 29339240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of anxiety disorder in adults with hidradenitis suppurativa.
    Cohn E; Palma G; Mastacouris N; Strunk A; Garg A
    Br J Dermatol; 2024 Aug; 191(3):351-356. PubMed ID: 38564268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hidradenitis suppurativa among patients with Down syndrome: a population-based cross-sectional analysis.
    Garg A; Strunk A; Midura M; Papagermanos V; Pomerantz H
    Br J Dermatol; 2018 Mar; 178(3):697-703. PubMed ID: 28662304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. African American race is a risk factor for severe hidradenitis suppurativa.
    Ulschmid C; Serrano L; Wu R; Roth GM; Sokumbi O
    Int J Dermatol; 2023 May; 62(5):657-663. PubMed ID: 36183313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hidradenitis suppurativa disproportionately affects African Americans: a single-center retrospective analysis.
    Vlassova N; Kuhn D; Okoye GA
    Acta Derm Venereol; 2015 Nov; 95(8):990-1. PubMed ID: 26073615
    [No Abstract]   [Full Text] [Related]  

  • 12. Overall and subgroup prevalence of acne vulgaris among patients with hidradenitis suppurativa.
    Wertenteil S; Strunk A; Garg A
    J Am Acad Dermatol; 2019 May; 80(5):1308-1313. PubMed ID: 30287328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overall and subgroup prevalence of pyoderma gangrenosum among patients with hidradenitis suppurativa: A population-based analysis in the United States.
    Tannenbaum R; Strunk A; Garg A
    J Am Acad Dermatol; 2019 Jun; 80(6):1533-1537. PubMed ID: 30738122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence estimates for pemphigoid in the United States: A sex-adjusted and age-adjusted population analysis.
    Wertenteil S; Garg A; Strunk A; Alloo A
    J Am Acad Dermatol; 2019 Mar; 80(3):655-659. PubMed ID: 30165164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher Risk of Care for Hidradenitis Suppurativa in African American and Non-Hispanic Patients in the United States.
    Udechukwu NS; Fleischer AB
    J Natl Med Assoc; 2017 Spring; 109(1):44-48. PubMed ID: 28259215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hidradenitis suppurativa in black pediatric patients - a national analysis of the kids' inpatient database.
    Singal A; Desai AD; Lipner SR
    Arch Dermatol Res; 2024 Sep; 316(9):616. PubMed ID: 39276244
    [No Abstract]   [Full Text] [Related]  

  • 17. Race-Specific Prevalence of Hidradenitis Suppurativa.
    Sachdeva M; Shah M; Alavi A
    J Cutan Med Surg; 2021; 25(2):177-187. PubMed ID: 33174482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnoracial representation in hidradenitis suppurativa clinical trials.
    Elhage KG; Davis MS; Hakimi M; Spencer RK; Jin JQ; Yeroushalmi S; Chung M; Bartholomew E; Bhutani T; Liao W
    Arch Dermatol Res; 2023 Aug; 315(6):1793-1796. PubMed ID: 36509944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: A population-based analysis in the United States.
    Garg A; Papagermanos V; Midura M; Strunk A; Merson J
    J Am Acad Dermatol; 2018 Sep; 79(3):495-500.e1. PubMed ID: 29499293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009.
    Dabelea D; Mayer-Davis EJ; Saydah S; Imperatore G; Linder B; Divers J; Bell R; Badaru A; Talton JW; Crume T; Liese AD; Merchant AT; Lawrence JM; Reynolds K; Dolan L; Liu LL; Hamman RF;
    JAMA; 2014 May; 311(17):1778-86. PubMed ID: 24794371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.